Gallia et al. performed whole exome sequencing (WES), whole genome sequencing (WGS) and SNP array analysis on 14 olfactory neuroblastoma patient samples and found that somatic DMD deletions occurred in 86% of the tumours [22]. The gene discussed is DMD; the disease is olfactory neuroblastoma.